Cite
HARVARD Citation
O'Brien, T. et al. (2020). Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial. Epilepsia. pp. 636-646. [Online].